← All companies
ASMB
Assembly Biosciences, Inc.
$25.36
-0.70 -2.69%
Key statistics
from XBRL data in SEC filingsMarket cap
$403M
Revenue (TTM)
$71.1M
Net income (TTM)
-$6.38M
EPS (TTM)
$0.08
P/E ratio
317.0
Dividend yield
—
Free cash flow
-$41.2M
Cash
$31.1M
Total assets
$236M
Gross margin
—
52-week range
$17.98 – $39.71
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Shareholder vote results
Jun 5, 2026
8-K
Entered a material agreement; Other events
May 26, 2026
8-K
Regulation FD disclosure; Other events
May 22, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release)
May 7, 2026
8-K
Director or officer change
Mar 30, 2026
10-K
Fiscal year ended 2025-12-31
Mar 19, 2026
8-K
Results of operations (earnings release)
Mar 19, 2026
8-K
Regulation FD disclosure; Other events
Dec 8, 2025
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Aug 11, 2025
8-K
Regulation FD disclosure; Other events
Aug 8, 2025
10-Q
Quarter ended 2025-06-30
Aug 6, 2025
8-K
Results of operations (earnings release); Other events
Aug 6, 2025
8-K
Other events
Jun 25, 2025
8-K
Director or officer change; Shareholder vote results
Jun 9, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
10-K
Fiscal year ended 2024-12-31
Mar 20, 2025
8-K
Results of operations (earnings release)
Mar 20, 2025
8-K
Other events
Feb 20, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jan 3, 2025
8-K
Other events
Dec 26, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Dec 19, 2024
8-K
Amended charter or bylaws
Dec 13, 2024
8-K
Entered a material agreement
Nov 7, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Other events
Sep 23, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Jun 18, 2024
8-K
Director or officer change; Shareholder vote results
Jun 3, 2024
10-Q
Quarter ended 2024-03-31
May 8, 2024
8-K
Results of operations (earnings release)
May 8, 2024
10-K
Fiscal year ended 2023-12-31
Mar 28, 2024
8-K
Results of operations (earnings release)
Mar 28, 2024
8-K
Director or officer change
Mar 15, 2024
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Feb 13, 2024